M&A Deal Summary

Salix Pharmaceuticals Acquires Santarus

On November 7, 2013, Salix Pharmaceuticals acquired life science company Santarus for 2.6B USD

Acquisition Highlights
  • This is Salix Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Salix Pharmaceuticals’ largest (disclosed) transaction.
  • This is Salix Pharmaceuticals’ 3rd transaction in the United States.
  • This is Salix Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary
Date 2013-11-07
Target Santarus
Sector Life Science
Buyer(s) Salix Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 2.6B USD
Advisor(s) Stifel, Nicolaus & Co., Inc. (Financial)
Latham & Watkins (Legal)

Target

Santarus

San Diego, California, United States
website
Santarus, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Salix Pharmaceuticals

Raleigh, North Carolina, United States

website

Category Company
Founded 1989
Sector Life Science
Revenue 933M USD (2013)
DESCRIPTION

Salix Pharmaceuticals Ltd. is a developer and marketer of prescription pharmaceutical products and medical devices for the prevention and treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic products, complete any required development and regulatory submission of these products, and market them through Salix's gastroenterology specialty sales and marketing team.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (California) 1 of 1
Country (United States) 3 of 3
Year (2013) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-08 Oceana Therapeutics

Edison, New Jersey, United States

Oceana Therapeutics, Inc., a privately-held provider of gastroenterology and urology therapeutics.

Buy -
Mergr

Product

Company

Legal